Concord Medical Services Holdings Limited (CCM)
NYSE: CCM · Real-Time Price · USD
4.415
+0.035 (0.80%)
Dec 20, 2024, 3:59 PM EST - Market closed

Company Description

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.

It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners.

In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel.

Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment.

Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services.

Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People’s Republic of China.

Concord Medical Services Holdings Limited
Concord Medical Services Holdings logo
Country China
Founded 1997
IPO Date Dec 11, 2009
Industry Medical Care Facilities
Sector Healthcare
Employees 727
CEO Jianyu Yang

Contact Details

Address:
East Zone, Hanwei Plaza, Room A1-A5, 26th Floor
Beijing, 100020
China
Phone 86 10 5903 6688
Website concordmedical.com

Stock Details

Ticker Symbol CCM
Exchange NYSE
Fiscal Year January - December
Reporting Currency CNY
CIK Code 0001472072
CUSIP Number 206277105
ISIN Number US2062771058
SIC Code 8011

Key Executives

Name Position
Dr. Jianyu Yang Chairman and Chief Executive Officer
Boxun Zhang Chief Financial Officer
Xun Liu Financial Controller

Latest SEC Filings

Date Type Title
Dec 9, 2024 6-K Report of foreign issuer
Nov 13, 2024 6-K Report of foreign issuer
Sep 27, 2024 6-K Report of foreign issuer
Sep 16, 2024 6-K Report of foreign issuer
Aug 29, 2024 6-K Report of foreign issuer
Aug 7, 2024 6-K Report of foreign issuer
Jul 31, 2024 6-K Report of foreign issuer
Jul 11, 2024 6-K Report of foreign issuer
Jul 11, 2024 F-6 POS Post-effective amendments for immediately effective filing
Apr 30, 2024 6-K Report of foreign issuer